Docetaxel

Land: Nieuw-Zeeland

Taal: Engels

Bron: Medsafe (Medicines Safety Authority)

Werkstoffen:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Beschikbaar vanaf:

REX Medical Ltd

INN (Algemene Internationale Benaming):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Dosering:

80 mg/mL

farmaceutische vorm:

Concentrate for infusion

Samenstelling:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Eenheden in pakket:

Vial, glass, Diluent, 6 mL

klasse:

Prescription

Prescription-type:

Prescription

Geproduceerd door:

Cipla Ltd

therapeutische indicaties:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Product samenvatting:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Autorisatie datum:

2006-06-23